GALNT12 is Not a Major Contributor of Familial Colorectal Cancer Type X

Previous evidence indicates that mutations in the GALNT12 gene might cause a fraction of the unexplained familial colorectal cancer (CRC) cases: GALNT12 is located in 9q22‐33, in close proximity to a CRC linkage peak; and germline missense variants that reduce the enzymatic activity of the protein have been identified in CRC patients, some of them with familial CRC history. We hypothesized that mutations in GALNT12 might explain part of the high‐risk families grouped as familial CRC type X (fCRC‐X), that is, Amsterdam‐positive families with mismatch repair proficient tumors. We sequenced the coding regions of the gene in 103 probands of fCRC‐X families, finding no functionally relevant mutations. Our results rule out GALNT12 as a major high CRC susceptibility gene. Additional studies are required to provide further evidence about its role as a moderate/low susceptibility gene in familial aggregation of cancer.

[1]  Y. Pawitan,et al.  Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X , 2012, Modern Pathology.

[2]  M. Woods,et al.  Inherited deleterious variants in GALNT12 are associated with CRC susceptibility , 2012, Human mutation.

[3]  M. Adams,et al.  Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22. , 2010, Cancer research.

[4]  Giovanni Parmigiani,et al.  Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers , 2009, Proceedings of the National Academy of Sciences.

[5]  H T Lynch,et al.  Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications , 2009, Clinical genetics.

[6]  B. Vogelstein,et al.  Genome-wide linkage scan for colorectal cancer susceptibility genes supports linkage to chromosome 3q , 2008, BMC Cancer.

[7]  R. Houlston,et al.  Evidence of linkage to chromosome 9q22.33 in colorectal cancer kindreds from the United Kingdom. , 2006, Cancer research.

[8]  A. Lindblom,et al.  Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32–31.1 , 2005, Journal of Medical Genetics.

[9]  H. Narimatsu,et al.  Expression of UDP-GalNAc:Polypeptide N-Acetylgalactosaminyltransferase-12 in Gastric and Colonic Cancer Cell Lines and in Human Colorectal Cancer , 2004, Oncology.

[10]  R. Elston,et al.  A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  K. Tachibana,et al.  Molecular cloning and characterization of a novel member of the UDP‐GalNAc:polypeptide N‐acetylgalactosaminyltransferase family, pp‐GalNAc‐T12 1 , 2002 .

[12]  K. Tachibana,et al.  Molecular cloning and characterization of a novel member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family, pp-GalNAc-T12. , 2002, FEBS letters.

[13]  Victor V. Solovyev,et al.  SpliceDB: database of canonical and non-canonical mammalian splice sites , 2001, Nucleic Acids Res..

[14]  S. Seal,et al.  Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22. , 1999, Gastroenterology.

[15]  David Haussler,et al.  Improved splice site detection in Genie , 1997, RECOMB '97.

[16]  Peter G. Korning,et al.  Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. , 1996, Nucleic acids research.